EKF Diagnostics, a manufacturer of point-of-care (POC) diagnostic tools, has introduced two new low-cost POC analysers: the new Quo-Lab glycated haemoglobin (HbA1c) analyser for the management of diabetes, and the STAT-Site M ?HB, a strip-based analyser for highly accurate near-patient testing of ketosis.
The semi-automated Quo-Lab HbA1c analyser is CE-marked and provides highly accurate, affordable and easy-to-use technology for GP surgeries, diabetes clinics and laboratories. HbA1c monitoring is increasingly used in the detection and management of diabetes and Quo-Lab is designed to meet the needs of economies where resources are limited and where diabetes is an increasingly large public health issue.
The launch of STAT Site M ?HB follows the recent success of the ?-hydroxybutyrate (?HB) LiquiColor reagent system developed by EKF subsidiary Stanbio Laboratory. The ?HB liquid stable reagent can be used on any open-channel analyser and is used by 13 of the USA’s top 25 diabetes and endocrinology hospitals to provide rapid, objective results.
www.ekfdiagnostics.com